Disclosures Alphabetical List

  • Cheri Abbott has no relevant financial relationships to disclose.
  • Steven Abman has received other grant or research support from United Therapeutics Corporation.
  • Christine Archer-Chicko has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd.
  • Rana Awdish has no relevant financial relationships to disclose.
  • Matthew Bacchetta has received institutional grant or research support from Johnson & Johnson.
  • David Badesch has served as a consultant, Advisory Board member or Steering Committee member for Acceleron Pharma, Inc., Actelion Pharmaceuticals Ltd., Arena Pharmaceuticals, Inc., Bellerophon Therapeutics, Liquidia Technologies, Complexa, Inc., United Therapeutics Corporation, and Respira Therapeutics, Inc. Badesch has received institutional grant or research support from Acceleron Pharma, Inc., Actelion Pharmaceuticals Ltd., Arena Pharmaceuticals, Inc., Bellerophon Therapeutics, Complexa, Inc., United Therapeutics Corporation, Eiger BioPharmaceuticals, Liquidia Technologies, Akros, National Insitutes of Health and United Therapeutics Corporation. Dr. Badesch is a self-managed stock shareholder in Johnson & Johnson.
  • Sonja Bartolome has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd. and Bayer HealthCare Pharmaceuticals LLC. Bartolome has served as a Speaker’s Bureau speaker for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC and Gilead Sciences, Inc.
  • Cecilia Beehler has no relevant financial relationships to disclose.
  • Thawit Benjapongsapun has no relevant financial relationships to disclose.
  • Matthew Beutner has no relevant financial relationships to disclose.
  • Sangeeta Bhorade has no relevant financial relationships to disclose.
  • Erick Borg is an employee of United Therapeutics
  • Evan Brittain has received institutional grant or research support from Gilead Sciences, Inc. and investigator initiated research support.
  • Anna Brown has no relevant financial relationships to disclose.
  • Lynette Brown has received institutional grant or research support from Bellerophon Therapeutics.
  • Bruce Brundage has served as a consultant, Advisory Board member or Steering Committee member for Acceleron Pharma, Inc., Bellerophon Therapeutics, Eiger BioPharmaceuticals, Inc., Lung Rx, LLC, Medtronic and United Therapeutics Corporation.
  • Colleen Brunetti is a self-managed stock shareholder in United Therapeutics Corporation.
  • Todd Bull has served as a consultant, Advisory Board member or Steering Committee member for Bellerophon Therapeutics, Liquidia Technologies and Bayer HealthCare Pharmaceuticals LLC. Bull has received institutional grant or research support from Bayer HealthCare Pharmaceuticals LLC.
  • Marla Burke has served as a consultant, Advisory Board member or Steering Committee member for Bayer HealthCare Pharmaceuticals LLC, Actelion Pharmaceuticals Ltd., and United Therapeutics Corporation. Burke has served as a Speaker’s Bureau speaker for Bayer HealthCare Pharmaceuticals LLC, Actelion Pharmaceuticals Ltd. and United Therapeutics Corporation.
  • Azalea Candelaria has no relevant financial relationships to disclose.
  • Michelle Cash received other grant or research support from Gilead Sciences, Inc. and 3,000 unrestricted educational grants.
  • Murali Chakinala has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd., Arena Pharmaceuticals, Inc., Bayer HealthCare Pharmaceuticals LLC, Express Scripts Holding Company, GlaxoSmithKline, Medscape, Reata Pharmaceuticals, Inc., Simply Speaking and United Therapeutics Corporation. Chakinala has served as a Speaker’s Bureau speaker for Gilead Sciences, Inc. and Bayer HealthCare Pharmaceuticals LLC. Dr. Chakinala has received institutional grant or research support from Actelion Pharmaceuticals Ltd., Arena Pharmaceuticals, Inc., Bayer HealthCare Pharmaceuticals LLC, Eiger BioPharmaceuticals, Inc., Liquidia Technologies, Medtronic plc, Novartis International AG and Reata Pharmaceuticals, Inc.
  • Kelly Chin has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd. and Arena Pharmaceuticals, Inc. Chin has received institutional grant or research support from Actelion Pharmaceuticals Ltd., Ironwood Pharmaceuticals, SoniVie and University of California, San Diego.
  • Lorinda Chung has served as a consultant, Advisory Board member or Steering Committee member for Reata Pharmaceuticals, Inc., Actelion Pharmaceuticals Ltd., Boehringer Ingelheim, Gilead Sciences, Inc., Incyte, Corp, Mitsubishi Tanabe Pharma Corporation, Third Rock Ventures and Global Blood Therapeutics. Chung has received institutional grant or research support from Bayer HealthCare Pharmaceuticals LLC, GlaxoSmithKline, United Therapeutics Corporation and Corbus Pharmaceuticals.
  • Colleen Connor has no relevant financial relationships to disclose.
  • Gerilynn Connors has no relevant financial relationships to disclose.
  • Nicole Creech has no relevant financial relationships to disclose.
  • Zhiyu Dai has no relevant financial relationships to disclose
  • Vinicio de Jesus Perez is a self-managed stock shareholder in Actelion Pharmaceuticals Ltd., Gilead Sciences, Inc., Pfizer, Inc. and Eiger BioPharmaceuticals, Inc.
  • Ramona Doyle is a self-managed stock shareholder in Roche Pharma and Gilead Sciences, Inc.
  • Hilary DuBrock has received other grant or research support from United Therapeutics Corporation.
  • Laura Duvall has no relevant financial relationships to disclose.
  • Jason Elinoff has no relevant financial relationships to disclose.
  • Greg Elliott has served as a consultant, Advisory Board member or Steering Committee member for Bayer HealthCare Pharmaceuticals LLC and Bellerophon Therapeutics. Dr. Elliott has received institutional grant or research support from Intermountain Research & Medical Foundation / Intermountain Healthcare. Elliott has received other grant or research support from Actelion Pharmaceuticals Ltd.
  • Harrison Farber has no relevant financial relationships to disclose
  • Jeffrey Fineman has received other grant or research support from Mallinckrodt Pharmaceuticals.
  • Jonathan Florentin has no relevant financial relationships to disclose.
  • Chris Forberg has no relevant financial relationships to disclose.
  • David Frank has no relevant financial relationships to disclose.
  • Hiroyuki Fukushima has received other grant or research support from Acceleron Pharma, Inc., Bayer HealthCare Pharmaceuticals LLC and Pfizer, Inc.
  • Stacey Gausling has no relevant financial relationships to disclose.
  • Simon Gibbs has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd., Arena Pharmaceuticals, Inc., Bellerophon Therapeutics, Pfizer, Inc., Complexa, Inc. and Bayer HealthCare Pharmaceuticals LLC. Gibbs has served as a Speaker’s Bureau speaker for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC and Merck & Co., Inc. Dr. Gibbs has received institutional grant or research support from Actelion Pharmaceuticals Ltd.
  • Mardi Gomberg-Maitland has no relevant financial relationships to disclose.
  • Elena Goncharova has received other grant or research support from Regeneron pharmaceuticals.
  • Brian Graham has received institutional grant or research support from the National Institutes of Health.
  • Michael Gray has no relevant financial relationships to disclose.
  • Dan Grinnan has received institutional grant or research support from United Therapeutics Corporation and Bayer HealthCare Pharmaceuticals LLC.
  • Carla Hall has no relevant financial relationships to disclose.
  • Stephanie Handler has no relevant financial relationships to disclose.
  • Gustavo Heresi has served as a consultant, Advisory Board member or Steering Committee member for Bayer HealthCare Pharmaceuticals LLC. Dr. Heresi has served as a Speaker’s Bureau speaker for Bayer HealthCare Pharmaceuticals LLC. Heresi has received institutional grant or research support from Bellerophon Therapeutics.
  • William Hoff has no relevant financial relationships to disclose.
  • Rachel Hopper has no relevant financial relationships to disclose.
  • Marc Humbert has served as a consultant, Advisory Board member or Steering Committee member for Acceleron Pharma, Inc., Arena Pharmaceuticals, Inc., GlaxoSmithKline; Merck & Co., Inc. and United Therapeutics Coporation. Humbert has received institutional grant or research support from Bayer HealthCare Pharmaceuticals LLC and GlaxoSmithKline.
  • Jessica Humphrey has no relevant financial relationships to disclose.
  • Dunbar Ivy has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC, Eli Lilly and Company; United Therapeutics Corporation and the Association for Pediatric Pulmonary Hypertension. Ivy has received institutional grant or research support from Actelion Pharmaceuticals Ltd., United Therapeutics Corporation, Eli Lilly and Company and Bayer HealthCare Pharmaceuticals LLC. Dr. Ivy has received other grant or research support from Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC, Eli Lilly and Company, United Therapeutics Corporation, National Institutes of Health and Food and Drug Administration.
  • William Jansen has no relevant financial relationships to disclose.
  • Adolfo Kaplan has no relevant financial relationships to disclose.
  • Steven Kawut has no relevant financial relationships to disclose.
  • Jamie Kennedy has no relevant financial relationships to disclose.
  • James Klinger has served as a consultant, Advisory Board member or Steering Committee member for Bayer HealthCare Pharmaceuticals LLC. Klinger has received institutional grant or research support from Eiger BioPharmaceuticals, Inc., Actelion Pharmaceuticals Ltd., Liquidia Technologies, Lung Rx, LLC and United therapeutics. Dr. Klinger has received other grant or research support from United Therapeutics Corporation.
  • Mitchell Koppelman is as a self-managed stock shareholder in Pfizer, Inc.
  • Richard Krasuski has served as a consultant, Advisory Board member or Steering Committee member for Acceleron Pharma, Inc. and VentriPoint Diagnostics. Krasuski has received institutional grant or research support from Actelion Pharmaceuticals Ltd.
  • Richard Kronmal has no relevant financial relationships to disclose.
  • Tim Lahm has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd. and Gilead Sciences, Inc. Lahm has served as a Speaker’s Bureau speaker for Bayer HealthCare Pharmaceuticals LLC. Dr. Lahm has received other grant or research support from Eli Lilly and Company.
  • Michael Landzberg has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd.
  • Peter Leary has served as a consultant, Advisory Board member or Steering Committee member for Bayer HealthCare Pharmaceuticals LLC.
  • Lauren Lefkowitz has no relevant financial relationships to disclose.
  • Ekaterina Legchenko has no relevant financial relationships to disclose.
  • Deborah Levine has no relevant financial relationships to disclose.
  • Martha Liberty has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC, Gilead Sciences, Inc. and United Therapeutics Corporation. Dr. Liberty has served as a Speaker’s Bureau speaker for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC, Gilead Sciences, Inc. and United Therapeutics Corporation.
  • Kimberley Litton has no relevant financial relationships to disclose.
  • Sagar Lonial has served as a consultant, Advisory Board member or Steering Committee member for Amgen, Inc., Bristol-Myers Squibb, Celgene Corporation, GlaxoSmithKline, Janssen Pharmaceutica, Merck & Company, Inc., Novartis International AG and Takeda Pharmaceutical Company Ltd.
  • Anne Lovig has no relevant financial relationships to disclose.
  • Sally Maddox has no relevant financial relationships to disclose.
  • Melissa Magness has no relevant financial relationships to disclose.
  • Kasey Malotte has no relevant financial relationships to disclose.
  • Natalie Marsh has served as a consultant, Advisory Board member or Steering Committee member for Amgen, Inc. Marsh has received other grant or research support from AstraZeneca plc.
  • Jennalyn Mayeux has no relevant financial relationships to disclose.
  • Susanne McDevitt has served as a consultant, Advisory Board member or Steering Committee member for United Therapeutics Corporation.
  • Sarah Miranda has no relevant financial relationships to disclose.
  • Barbara Monaghan has no relevant financial relationships to disclose.
  • David Montani has no relevant financial relationships to disclose.
  • Nicholas Morrell has served as a consultant, Advisory Board member or Steering Committee member for Johnson & Johnson and GlaxoSmithKline. Morrell has received institutional grant or research support from Morphogen-IX. Dr. Morrell is a self-managed stock shareholder in Morphogen-IX. Dr. Morrell is employed as 0.5FTE CEO of Morphogen-IX.
  • Steven Nathan has served as a consultant, Advisory Board member or Steering Committee member for United Therapeutics Corporation, Bayer HealthCare Pharmaceuticals LLC and Actelion Pharmaceuticals Ltd. Nathan has served as a Speaker’s Bureau speaker for Bayer HealthCare Pharmaceuticals LLC. Dr. Nathan has received institutional grant or research support from Bellerophon Therapeutics and Bayer HealthCare Pharmaceuticals LLC.
  • John Newman has no relevant financial relationships to disclose.
  • Olivia Onyeador has no relevant financial relationships to disclose.
  • Regina Overton-Barnes has no relevant financial relationships to disclose.
  • Roxane Paulin has no relevant financial relationships to disclose.
  • Janet Pinson has no relevant financial relationships to disclose.
  • Abby Poms has served as a consultant, Advisory Board member or Steering Committee member for Guidemark Health.
  • Barbara Prendes has no relevant financial relationships to disclose.
  • Fahim Pyarali has no relevant financial relationships to disclose.
  • Marlene Rabinovitch has no relevant financial relationships to disclose.
  • Margarita Rodriguez has no relevant financial relationships to disclose.
  • Josanna Rodriguez-Lopez has received institutional grant or research support from Actelion Pharmaceuticals Ltd.
  • Erik Rodriquez has no relevant financial relationships to disclose.
  • James Runo has no relevant financial relationships to disclose.
  • Allyson Rupp has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd. and faculty member for “Beyond the Basics” through Guidemark Health, sponsored by Actelion Pharmaceuticals Ltd. Rupp has served as a Speaker’s Bureau speaker for Actelion Pharmaceuticals Ltd. and for Beyond the Basics.
  • Zeenat Safdar has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC, Boehringer Ingelheim, Genentech, Inc., United Therapeutics Corporation and Gilead Sciences, Inc. Safdar has served as a Speaker’s Bureau speaker for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC, Genentech, Inc., Boehringer Ingelheim, United Therapeutics Coporation and Gilead Sciences, Inc.
  • Michael Salinero has no relevant financial relationships to disclose.
  • Kristen Schaefer has no relevant financial relationships to disclose.
  • Ann Schmit has no relevant financial relationships to disclose.
  • Renee Schnug has no relevant financial relationships to disclose.
  • Trushil Shah has served as a consultant, Advisory Board member or Steering Committee member for Gilead Sciences, Inc. Shah has served as a Speaker’s Bureau speaker for Gilead Sciences, Inc. Dr. Shah has received institutional grant or research support from Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC and Liquidia Technologies.
  • Oksana Shlobin has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC, United Therapeutics Corporation and Lung Rx, LLC. Shlobin has served as a Speaker’s Bureau speaker for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC, Lung Rx, LLC, andUnited Therapeutics Corporation.
  • Olivier Sitbon has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd., Merck & Co., Inc., Bayer HealthCare Pharmaceuticals LLC and GlaxoSmithKline. Sitbon has received institutional grant or research support from Actelion Pharmaceuticals Ltd., Merck & Co., Inc., Bayer HealthCare Pharmaceuticals LLC and GlaxoSmithKline.
  • Karen Smaalders has no relevant financial relationships to disclose.
  • Namita Sood has no relevant financial relationships to disclose.
  • Norman Stockbridge has no relevant financial relationships to disclose.
  • John Swisher has served as a Speaker’s Bureau speaker for Actelion Pharmaceuticals Ltd., Bayer HealthCare Pharmaceuticals LLC, Gilead Sciences, Inc. and United Therapeutics Corporation. Swisher has received institutional grant or research support from United Therapeutics Corporation.
  • Arunabh Talwar has served as a consultant, Advisory Board member or Steering Committee member for Boehringer Ingelheim and Genentech, Inc.
  • Elizabeth Tarka is an employee of Complexa, Inc.
  • Douglas Taylor is a self-managed stock shareholder in United Therapeutics Corporation.
  • Thenappan Thenaappan has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd. and Gilead Sciences, Inc. Thenaappan has served as a Speaker’s Bureau speaker for Medscape.
  • Uyen Truong has no relevant financial relationships to disclose.
  • Anjali Vaidya has served as a consultant, Advisory Board member or Steering Committee member for Actelion Pharmaceuticals Ltd. and United Therapeutics Corporation. Vaidya has served as a Speaker’s Bureau speaker for Actelion Pharmaceuticals Ltd., Gilead Sciences, Inc., United Therapeutics Corporation and Bayer HealthCare Pharmaceuticals LLC.
  • Nidhy Varghese received institutional grant or research support from United Therapeutics Corporation. Varghese has other personal financial relationships with Up To Date as an editor.
  • Corey Ventetuolo has served as a consultant, Advisory Board member or Steering Committee member for Acceleron Pharma, Inc., Bayer HealthCare Pharmaceuticals LLC and United Therapeutics Corporation. Ventetuolo has received institutional grant or research support from Actelion Pharmaceuticals Ltd. and Eiger BioPharmaceuticals, Inc. Dr. Ventetuolo’s spouse is an employee of CVS Health.
  • Tania Von Visger has no relevant financial relationships to disclose.
  • Patricia Wasserman has no relevant financial relationships to disclose.
  • Aaron Waxman has served as a consultant, Advisory Board member or Steering Committee member for United Therapeutics Corporation and Gossamer Bio Inc.
  • Aaron Weinberg has no relevant financial relationships to disclose.
  • Christian Wigley is a self-managed stock shareholder in Reata Pharmaceuticals, Inc.
  • Kayleen Williams is an employee of the University of Washington and receives funding for her work from the Pulmonary Hypertension Association Registry.
  • Timothy Williamson has received institutional grant or research support from United Therapeutics Corporation, Bayer HealthCare Pharmaceuticals LLC and Liquidia Technologies.
  • James Wilson has no relevant financial relationships to disclose.
  • Kimberly Winters has served as a consultant, Advisory Board member or Steering Committee member for Gilead Sciences, Inc.
  • Brad A. Wong has no relevant financial relationships to disclose.
  • Lincai Ye has no relevant financial relationships to disclose.
  • Delphine Yung has received institutional grant or research support from United Therapeutics Corporation and Actelion Pharmaceuticals Ltd.
  • Tonya Zeiger has no relevant financial relationships to disclose.

Last Updated: Nov., 2018, 2016